Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | RAC2 | P15153 | 1/20 | 0.43 |
| ▸ | RAC3 | P60763 | 1/20 | 0.43 |
| ▸ | CDC42 | P60953 | 1/20 | 0.43 |
| ▸ | RAC1 | P63000 | 1/20 | 0.43 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.41 |
| ▸ | APP | P05067 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.38 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12123250 | 0.97 | L3MBTL1 (0.49) | L3MBTL1KDM4EATMRAC2RAC3 | |
| SCHEMBL12123233 | 0.93 | L3MBTL1 (0.55) | L3MBTL1KDM4EATMRAC2RAC3 | |
| SCHEMBL12123249 | 0.92 | L3MBTL1 (0.46) | L3MBTL1KDM4EATMRAC2RAC3 | |
| SCHEMBL12123243 | 0.91 | KDM4E (0.45) | L3MBTL1KDM4EATMRAC2RAC3 | |
| SCHEMBL12123253 | 0.91 | KDM4E (0.45) | L3MBTL1KDM4EATMRAC2RAC3 | |
| SCHEMBL12123240 | 0.90 | L3MBTL1 (0.52) | L3MBTL1KDM4EATMRAC2RAC3 | |
| SCHEMBL14900940 | 0.89 | KDM4E (0.43) | L3MBTL1KDM4EATMRAC2RAC3 | |
| SCHEMBL12123248 | 0.89 | KDM4E (0.43) | L3MBTL1KDM4EATMRAC2RAC3 | |
| SCHEMBL12123244 | 0.89 | L3MBTL1 (0.43) | L3MBTL1KDM4EATMRAC2RAC3 | |
| SCHEMBL12123259 | 0.89 | KDM4E (0.43) | L3MBTL1KDM4EATMRAC2RAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8057920-B2 | Heterocyclic compound and organic light emitting device comprising the same | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2011-11-15 | — | — | US | disclosed |
| US-8057920-B2 | Heterocyclic compound and organic light emitting device comprising the same | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2011-11-15 | — | — | US | disclosed |
| EP-2060574-B1 | Heterocyclic compound and an organic light emitting device comprising the same | SAMSUNG MOBILE DISPLAY CO LTD (KR) | 2011-08-17 | — | — | EP | disclosed |
| US-7846559-B2 | Heterocyclic compound and an organic light emitting device comprising the same | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2010-12-07 | — | — | US | disclosed |
| US-7846559-B2 | Heterocyclic compound and an organic light emitting device comprising the same | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2010-12-07 | — | — | US | disclosed |
| US-20090146555-A1 | Heterocyclic compound and organic light emitting device comprising the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-06-11 | — | — | US | disclosed |
| US-20090146555-A1 | Heterocyclic compound and organic light emitting device comprising the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-06-11 | — | — | US | disclosed |
| US-20090128013-A1 | Heterocyclic compound and an organic light emitting device comprising the same | SAMSUNG SDI CO, LTD (KR) | 2009-05-21 | — | — | US | disclosed |
| US-20090128013-A1 | Heterocyclic compound and an organic light emitting device comprising the same | SAMSUNG SDI CO, LTD (KR) | 2009-05-21 | — | — | US | disclosed |
| EP-2060574-A1 | Heterocyclic compound and an organic light emitting device comprising the same | Samsung Mobile Display Co., Ltd. (KR) | 2009-05-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090128013-A1 | Heterocyclic compound and an organic light emitting device comprising the same | CRY1, NR2E3, AR | L3MBTL1 1668/4885KDM4E 2403/4885ATM 2340/4885 |
| US-20090146555-A1 | Heterocyclic compound and organic light emitting device comprising the same | TRPC1, TRPC3, TRPC4 | L3MBTL1 2775/4885KDM4E 4097/4885ATM 3666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.